✦ LIBER ✦

Prognostic Impact of Deficient DNA Mismatch Repair in Patients With Stage III Colon Cancer From a Randomized Trial of FOLFOX-Based Adjuvant Chemotherapy

✍ Scribed by Sinicrope, F. A.; Mahoney, M. R.; Smyrk, T. C.; Thibodeau, S. N.; Warren, R. S.; Bertagnolli, M. M.; Nelson, G. D.; Goldberg, R. M.; Sargent, D. J.; Alberts, S. R.

Book ID: 121371837
Publisher: American Society of Clinical Oncology
Year: 2013
Tongue: English
Weight: 240 KB
Volume: 31
Category: Article
ISSN: 0732-183X
DOI: 10.1200/JCO.2013.48.9591

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prognostic Value of Mucinous Histology D

Prognostic Value of Mucinous Histology Depends on Microsatellite Instability Status in Patients with Stage III Colon Cancer Treated with Adjuvant FOLFOX Chemotherapy: A Retrospective Cohort Study

✍ Kim, Se Hyun; Shin, Sang Joon; Lee, Kang Young; Kim, Hyunki; Kim, Tae Il; Kang, 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 269 KB

622 POSTER Prognostic factors in patient

622 POSTER Prognostic factors in patients with colon cancer receiving adjuvant 5-FU-based chemotherapy: analysis of a randomized trial including 855 patients

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 141 KB

Toxicity of Oxaliplatin Plus Fluorouraci

Toxicity of Oxaliplatin Plus Fluorouracil/Leucovorin Adjuvant Chemotherapy in Elderly Patients with Stage III Colon Cancer: A Population-Based Study

✍ Hamza, Samia; Bouvier, Anne-Marie; Rollot, Fabien; Lepage, Côme; Faivre, Jean; B 📂 Article 📅 2014 🏛 Springer 🌐 English ⚖ 254 KB

6010 A three-arm phase III randomized tr

6010 A three-arm phase III randomized trial of FOLFOX-4 vs. FOLFOX-4 plus bevacizumab vs. XELOX plus bevacizumab in the adjuvant treatment of patients with stage III or high-risk stage II colon cancer: results of the interim safety analysis of the AVANT trial

✍ Hoff, P.; Clarke, S.; Cunningham, D.; Van Cutsem, E.; Moore, M.; Schmoll, H.J.; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 48 KB

Assessing the initiation and completion

Assessing the initiation and completion of adjuvant chemotherapy in a large nationwide and population-based cohort of elderly patients with stage-III colon cancer

✍ Chung-Yuan Hu; George L. Delclos; Wenyaw Chan; Xianglin L. Du 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 264 KB

Impact of Age on the Efficacy of Newer A

Impact of Age on the Efficacy of Newer Adjuvant Therapies in Patients With Stage II/III Colon Cancer: Findings From the ACCENT Database

✍ McCleary, N. J.; Meyerhardt, J. A.; Green, E.; Yothers, G.; de Gramont, A.; Van 📂 Article 📅 2013 🏛 American Society of Clinical Oncology 🌐 English ⚖ 258 KB